Eye health and ophthalmology companies develop diagnostics, treatments and research technologies for conditions affecting vision and the structures of the eye. Their work supports earlier disease detection, improved patient monitoring and the development of new ocular therapies.
This category includes companies working on:
Browse 23 UK eye health and ophthalmology companies below.
Gene therapy company targeting complement-mediated ocular diseases
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies and protein-based therapeutics for diseases driven by dysregulation of the complement…
Specialist preclinical CRO for ophthalmic retinal disease drug development
MediNect Ophtho is a contract research organisation providing specialist preclinical services for ophthalmic drug development, with an exclusive focus on retinal disease.…
TSG-6 protein therapeutics for inflammatory and degenerative disease
Link Biologics is a preclinical-stage biotechnology company developing protein therapeutics based on TSG-6, an endogenous human protein with anti-inflammatory and…
RNA therapeutics targeting cellular senescence and age-related disease
Senisca is a preclinical-stage biotechnology company developing oligonucleotide and small molecule therapeutics that reverse cellular senescence by restoring RNA splicing factor…
Human iPSC-derived cells and services for drug discovery research
Axol Bioscience is a biotechnology company manufacturing and supplying human induced pluripotent stem cell-derived cells and outsourced laboratory services for drug discovery and…
Bicistronic AAV gene therapies for retinal disease
Ikarovec is a near-clinical-stage gene therapy company developing bicistronic AAV-based therapeutics for vision-threatening retinal diseases. Its proprietary platform combines two…
AI clinical decision support for macular and retinal disease
Macusoft is a London-based health technology company developing AI-powered software to support clinical decision-making in ophthalmology. Its platform assists with diagnosis,…
Long-acting eye-drop matrix technology for chronic ocular surface disease
Healome Therapeutics is a University of Birmingham spin-out developing a proprietary eye-drop matrix technology that improves drug retention, lubrication and healing on the eye…
GPCR-targeting ophthalmic therapeutics for dry eye and corneal pain
OKYO Pharma is a clinical-stage biopharmaceutical company developing treatments for inflammatory eye diseases and chronic ocular pain. Its lead candidate, urcosimod, is a…
Nanotechnology drug delivery platform for precision medicines
Nanomerics is a UK speciality pharmaceutical company developing precision medicines using its proprietary technology, a polymer nanotechnology platform that improves the…
In vivo cell reprogramming therapies for degenerative disease
Mogrify is a biotechnology company developing a novel class of in vivo reprogramming therapies for degenerative diseases. Its proprietary platforms use large-scale transcriptomic…
Ophthalmic therapeutics for presbyopia, cataracts, and geographic atrophy
Tenpoint Therapeutics is a clinical-stage biotechnology company developing therapeutics for age-related ocular diseases. Its pipeline comprises three programmes: BRIMOCHOL PF, a…